Request Free Sample ×
ReportInfographic

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background
English
Chinese
French
Japanese
Korean
German
Spanish

Heart Transplant Market Trends

ID: MRFR/MED/1304-HCR
80 Pages
Nidhi Mandole
March 2026

Heart Transplant Market Research Report Information By Type (Ventricular Assisted Device, Total Artificial hearts and Others), By End User (Hospitals, Cardiac Institutes, and Others), and By Region (North America, Europe, Asia-Pacific, and Rest Of The World) - Growth & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Heart Transplant Market Infographic
Request Free Sample
Purchase Options
Compare License
Summary Table of Contents Segmentation Download PDF

Market Trends

Key Emerging Trends in the Heart Transplant Market

The Heart transplant market is witnessing a constant growth in demand, mainly because of the growing prevalence of cease-level heart sicknesses. As cardiovascular situations turn out to be extra general globally, the want for heart transplants as a lifestyle-saving intervention is on the upward thrust. Continuous improvements in transplantation technology are riding the Heart transplant market. Improved surgical strategies, organ maintenance strategies, and publish-transplant care contribute to higher patient results, lowering complications and enhancing the achievement fees of heart transplants. The popularity and integration of regenerative medication within the field of heart transplantation are emerging trends. Research and improvement in regenerative cures purpose to decorate organ viability, lessen rejection costs, and, in the long run, improve the long-term achievement of heart transplants. The development of progressive immunosuppressive treatments is a key trend within the Heart transplant market. These treatments intend to balance the suppression of the immune gadget to save you from rejection while minimizing facet effects, thereby enhancing the general first-class of life for transplant recipients. Collaborative efforts between public and personal entities are driving research and improvement in the Heart transplant market. Partnerships among instructional institutions, pharmaceutical groups, and healthcare companies are fostering innovation, leading to the invention of new capsules and remedy techniques for transplant recipients. Regulatory reforms and coverage modifications related to organ transplantation are impacting the Heart transplant market. Governments and fitness businesses are operating to streamline organ allocation strategies, improve transplant infrastructure, and deal with moral issues, contributing to more prepared and efficient transplantation surroundings. The trend of medical tourism for heart transplants is gaining traction. Patients are searching for transplantation offerings in international locations known for their understanding and superior medical facilities, contributing to the globalization of the heart transplant market. Despite high-quality developments, challenges related to the fee and accessibility of heart transplants persist. Efforts are ongoing to cope with these challenges through medical insurance reforms, monetary assistance programs, and consciousness campaigns to make sure that life-saving heart transplant processes are reachable to a broader population.

Author
Author Profile
Nidhi Mandole
Senior Research Analyst

She is an extremely curious individual currently working in Healthcare and Medical Devices Domain. Nidhi is comfortably versed in data centric research backed by healthcare educational background. She leverages extensive data mining and analytics tools such as Primary and Secondary Research, Statistical Analysis, Machine Learning, Data Modelling. Her key role also involves Technical Sales Support, Client Interaction and Project management within the Healthcare team. Lastly, she showcases extensive affinity towards learning new skills and remain fascinated in implementing them.

Get In Touch

Leave a Comment

FAQs

What is the current valuation of the Heart Transplant Market as of 2024?

<p>The Heart Transplant Market was valued at 12.33 USD Billion in 2024.</p>

What is the projected market size for the Heart Transplant Market by 2035?

<p>The market is projected to reach 35.54 USD Billion by 2035.</p>

What is the expected CAGR for the Heart Transplant Market during the forecast period 2025 - 2035?

<p>The expected CAGR for the Heart Transplant Market during 2025 - 2035 is 10.1%.</p>

Which application segment is projected to have the highest growth in the Heart Transplant Market?

<p>The Coronary Artery Disease segment is projected to grow from 4.0 USD Billion in 2024 to 11.0 USD Billion by 2035.</p>

How does the market size for living donor transplants compare to deceased donor transplants?

<p>In 2024, the market for living donor transplants was 4.93 USD Billion, while deceased donor transplants were valued at 7.4 USD Billion.</p>

What are the key players in the Heart Transplant Market?

<p>Key players include Abbott, Medtronic, Boston Scientific, and Terumo Corporation, among others.</p>

Which end-use segment is expected to see the most significant growth by 2035?

The Hospitals segment is expected to grow from 4.93 USD Billion in 2024 to 14.14 USD Billion by 2035.

What is the market size for pediatric heart transplants compared to adult and geriatric transplants?

Pediatric heart transplants were valued at 1.23 USD Billion in 2024, while adult and geriatric transplants were valued at 7.33 USD Billion and 3.77 USD Billion, respectively.

How does the gender distribution in the Heart Transplant Market appear?

In 2024, the market for male heart transplant patients was 7.4 USD Billion, compared to 4.93 USD Billion for female patients.

What trends are anticipated in the Heart Transplant Market by 2035?

The market is likely to experience substantial growth across all segments, driven by advancements in medical technology and increasing patient demand.

Market Summary

As per MRFR analysis, the Heart Transplant Market Size was estimated at 12.33 USD Billion in 2024. The Heart Transplant industry is projected to grow from 13.58 USD Billion in 2025 to 35.54 USD Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 10.1% during the forecast period 2025 - 2035.

Key Market Trends & Highlights

The Heart Transplant Market is experiencing robust growth driven by technological advancements and increasing demand for organ transplantation.

  • North America remains the largest market for heart transplants, driven by advanced healthcare infrastructure and high patient awareness.
  • The Asia-Pacific region is emerging as the fastest-growing market, fueled by increasing healthcare investments and a rising population with heart diseases.
  • Cardiac failure represents the largest segment in the heart transplant market, while coronary artery disease is noted as the fastest-growing segment.
  • Key market drivers include the increasing prevalence of heart diseases and advancements in surgical techniques, which are enhancing transplant outcomes.

Market Size & Forecast

2024 Market Size 12.33 (USD Billion)
2035 Market Size 35.54 (USD Billion)
CAGR (2025 - 2035) 10.1%
Largest Regional Market Share in 2024 North America

Major Players

Medtronic (US), Abbott Laboratories (US), Boston Scientific (US), Terumo Corporation (JP), Cardinal Health (US), Baxter International (US), Edwards Lifesciences (US), Janssen Pharmaceuticals (US), Sorin Group (IT)

Market Trends

The Heart Transplant Market is currently experiencing a dynamic evolution, driven by advancements in medical technology and an increasing understanding of transplant immunology. As healthcare systems worldwide strive to enhance patient outcomes, there is a notable emphasis on improving organ preservation techniques and post-operative care. This focus not only aims to increase the longevity of transplanted organs but also seeks to minimize complications associated with heart transplants. Furthermore, the growing prevalence of heart diseases necessitates a more robust approach to organ transplantation, thereby propelling research and development in this sector. In addition, the Heart Transplant Market is witnessing a shift towards personalized medicine, where treatment plans are tailored to individual patient profiles. This trend is indicative of a broader movement within healthcare, emphasizing the importance of patient-centric approaches. As the market continues to evolve, collaboration among healthcare providers, researchers, and regulatory bodies appears essential to address the challenges of organ shortages and to enhance the overall efficacy of heart transplantation. The future landscape of this market seems promising, with ongoing innovations likely to reshape the way heart transplants are conducted and managed.

Technological Advancements in Transplant Procedures

The Heart Transplant Market is increasingly influenced by technological innovations that enhance surgical techniques and patient monitoring. These advancements may lead to improved surgical outcomes and reduced recovery times, thereby attracting more patients to consider transplantation as a viable option.

Growing Demand for Organ Transplantation

There is a rising need for heart transplants due to the increasing incidence of cardiovascular diseases. This trend suggests that healthcare systems must adapt to meet the growing demand, potentially leading to more efficient organ allocation processes and improved patient access.

Focus on Post-Transplant Care

The emphasis on post-operative care is becoming more pronounced within the Heart Transplant Market. Enhanced follow-up protocols and patient education initiatives may contribute to better long-term outcomes, indicating a shift towards comprehensive care models that prioritize patient well-being after surgery.

Heart Transplant Market Market Drivers

Aging Population

The aging population is a significant driver of the Global Heart Transplant Market Industry. As individuals age, the risk of developing heart-related conditions increases, leading to a higher demand for heart transplants. In many countries, the demographic shift towards an older population necessitates enhanced healthcare services, including transplant programs. This trend is particularly evident in developed nations where life expectancy is rising. Consequently, the market is poised for growth as healthcare systems adapt to meet the needs of an aging population. The increasing number of elderly patients requiring heart transplants underscores the urgency for effective healthcare solutions.

Market Growth Projections

The Global Heart Transplant Market Industry is projected to experience substantial growth over the next decade. With a market valuation of 12.3 USD Billion in 2024, it is anticipated to reach 35.5 USD Billion by 2035. This growth trajectory suggests a CAGR of 10.1% from 2025 to 2035, indicating a robust demand for heart transplant procedures and related technologies. Factors contributing to this growth include advancements in medical technology, increasing awareness of organ donation, and a rising incidence of heart diseases. These projections highlight the potential for significant developments within the industry, shaping the future of heart transplantation.

Advancements in Medical Technology

Technological innovations play a pivotal role in the Global Heart Transplant Market Industry. The development of advanced surgical techniques, improved immunosuppressive therapies, and enhanced organ preservation methods have significantly increased transplant success rates. For instance, the introduction of minimally invasive surgical procedures has reduced recovery times and improved patient outcomes. As a result, the market is projected to grow at a CAGR of 10.1% from 2025 to 2035, reaching an estimated 35.5 USD Billion by 2035. These advancements not only facilitate more successful transplants but also encourage more patients to consider heart transplantation as a viable treatment option.

Rising Incidence of Heart Diseases

The Global Heart Transplant Market Industry is experiencing growth driven by the increasing prevalence of heart diseases. Factors such as sedentary lifestyles, unhealthy diets, and rising obesity rates contribute to this trend. In 2024, the market is valued at 12.3 USD Billion, reflecting the urgent need for heart transplants. The World Health Organization indicates that cardiovascular diseases remain the leading cause of death globally, prompting healthcare systems to prioritize transplant procedures. This rising incidence not only highlights the demand for heart transplants but also emphasizes the need for advanced medical technologies and improved healthcare infrastructure.

Regulatory Support and Funding Initiatives

Regulatory support and funding initiatives are crucial for the Global Heart Transplant Market Industry. Governments and health organizations are increasingly recognizing the importance of heart transplantation as a life-saving procedure. This recognition has led to the establishment of funding programs aimed at supporting transplant research and improving healthcare infrastructure. Additionally, regulatory bodies are streamlining the approval processes for new transplant technologies and therapies, facilitating quicker access to innovative solutions. Such support not only enhances the overall transplant landscape but also encourages investment in research and development, ultimately benefiting patients awaiting heart transplants.

Growing Awareness and Acceptance of Organ Donation

The Global Heart Transplant Market Industry benefits from increasing awareness and acceptance of organ donation. Public health campaigns and educational initiatives have played a crucial role in changing perceptions about organ donation. As more individuals recognize the importance of donating organs, the number of available hearts for transplantation is likely to rise. This shift in societal attitudes could lead to a more robust supply of organs, thereby supporting the growth of the market. Furthermore, government policies promoting organ donation are expected to enhance the overall transplant ecosystem, ultimately benefiting patients in need of heart transplants.

Market Segment Insights

By Application: Cardiac Failure (Largest) vs. Coronary Artery Disease (Fastest-Growing)

In the Heart Transplant Market, Cardiac Failure holds the largest share among the application segments, significantly leading due to its high prevalence in the aging population. This condition necessitates heart transplants as a primary treatment option, which subsequently drives the market's robustness in this category. Conversely, Coronary Artery Disease is emerging as the fastest-growing segment, propelled by increasing rates of obesity and lifestyle-related health issues. Its growth can also be attributed to advancements in diagnosis and treatment that enhance patients' survival rates and increase the demand for transplants.

Cardiac Failure (Dominant) vs. Congenital Heart Defects (Emerging)

Cardiac Failure, the dominant application segment, is characterized by its alarming rates within the elderly demographic, necessitating immediate and advanced medical interventions, including heart transplants. This segment remains crucial as it encompasses a wide range of heart-related dysfunctions that lead to extreme cases requiring transplant solutions. In contrast, Congenital Heart Defects, labeled as an emerging segment, are witnessing heightened attention due to increasing awareness and diagnostic strategies that allow for earlier intervention and management of heart defects, significantly impacting patient outcomes. As both segments align with evolving healthcare practices and patient demographics, they underscore the dynamic nature of the Heart Transplant Market.

By End Use: Hospitals (Largest) vs. Specialized Heart Clinics (Fastest-Growing)

<p>In the Heart Transplant Market, hospitals dominate the end-use segment due to their comprehensive facilities and resources for performing complex surgeries. Hospitals are essential in providing post-operative care and monitoring for heart transplant patients, thus holding a significant market share. Specialized heart clinics, while smaller in comparison, have begun to carve out a notable position by offering targeted services and expertise which appeal to an increasing number of patients seeking specialized cardiac care.</p>

<p>Hospitals (Dominant) vs. Specialized Heart Clinics (Emerging)</p>

<p>Hospitals serve as the dominant force in the heart transplant market, equipped with advanced medical technology, teams of specialized healthcare professionals, and integrated care facilities. Their comprehensive approach encompasses transplant surgery, recovery, and long-term patient management. On the other hand, specialized heart clinics are emerging rapidly, focusing on tailored services including assessments, pre-transplant evaluations, and follow-up care. These clinics are able to deliver personalized attention, which enhances patient outcomes and satisfaction. As awareness of heart health and transplant options grows, these clinics are increasingly recognized, contributing to their swift growth and importance in the overall market.</p>

By Type of Donor: Deceased Donor (Largest) vs. Living Donor (Fastest-Growing)

<p>In the Heart Transplant Market, the distribution of donors is a critical factor influencing transplant success rates and patient outcomes. Currently, deceased donors account for the largest share of donor organs, representing the primary source for heart transplantation. As the demand for heart transplants grows, deceased donors remain a key component to meeting this urgent need, often leading to better tissue matching and wider availability for patients in critical condition. However, this segment is constrained by the limited availability of suitable organs, reflecting an ongoing challenge in the transplant community. Conversely, the living donor segment is emerging as the fastest-growing source of heart transplants. With advancements in surgical techniques and a greater awareness of the benefits of living donation, more individuals are opting to donate their hearts while alive, offering a vital alternative to deceased donation. This trend is expected to continue due to the increased number of health campaigns promoting living donations and the growing acceptance of this life-saving option among patients and families, thereby reducing waiting times and improving overall transplant success rates.</p>

<p>Deceased Donor (Dominant) vs. Living Donor (Emerging)</p>

<p>Deceased donors comprise the dominant portion of the Heart Transplant Market, providing a significant number of organs for transplantation. This category is characterized by organs retrieved from individuals who have passed away, with stringent medical and ethical guidelines governing the donation process. The critical advantage of deceased donors includes broader availability of organs in emergencies and a more extensive database of eligible tissues, ensuring higher matching rates for recipients. Meanwhile, living donors are becoming an emerging segment as awareness surrounding the benefits of living donation increases. Living donors often lead to improved outcomes for recipients, as they typically experience better organ function and reduced waiting times. This segment, while still smaller, is gaining momentum driven by medical advancements and heightened societal awareness, positioning it as a formidable player in the transplant market.</p>

By Age Group: Adult (Largest) vs. Geriatric (Fastest-Growing)

<p>The Heart Transplant Market shows a diverse distribution of segments across different age groups. Among these, the Adult segment holds the largest share, primarily driven by the increasing prevalence of heart diseases in middle-aged populations. In contrast, the Geriatric segment has emerged as a significant focus for healthcare providers due to the growing elderly population and their heightened vulnerability to cardiovascular diseases. Pediatric heart transplants, while crucial, remain a smaller portion of the market, reflecting specific medical needs and advancements in pediatric cardiac care. In terms of growth trends, the Geriatric segment is witnessing the fastest expansion, owing to advancements in surgical techniques and post-operative care, which have improved outcomes for older patients. This shift is complemented by increasing awareness and acceptance of heart transplantation among older adults and their families. Additionally, the rising incidence of comorbidities in the geriatric population has led to a greater demand for heart transplants, making this age group a critical area for future market development.</p>

<p>Adult (Dominant) vs. Pediatric (Emerging)</p>

<p>The Adult age group stands as the dominant force in the Heart Transplant Market, owing to a combination of high prevalence rates of heart diseases, comprehensive care protocols, and established surgical practices tailored to older adolescents and adults. Patients in this segment often present with various lifestyle-related cardiovascular issues, which necessitates advanced medical interventions like heart transplants. Conversely, the Pediatric segment, while currently emerging, presents unique challenges and opportunities. Pediatric heart transplantation is a specialized field facing limitations due to donor availability and complex surgical requirements. Despite being smaller in scale, advancements in <a href="https://www.marketresearchfuture.com/reports/pediatric-cardiology-market-37071" target="_blank" title="pediatric cardiology">pediatric cardiology</a> and an increased focus on congenital heart defects are driving growth in this segment, showcasing its potential importance in the market.</p>

By Gender: Male (Largest) vs. Female (Fastest-Growing)

<p>In the Heart Transplant Market, the gender segment reveals a significant distribution in market share. Males constitute the largest portion of heart transplant recipients, reflecting historical trends where men have typically faced higher instances of heart diseases. This segment's prevalence is influenced by both biological risk factors and lifestyle choices, making them a focal point in transplantation statistics.</p>

<p>Gender: Male (Dominant) vs. Female (Emerging)</p>

<p>Males represent the dominant demographic in the Heart Transplant Market, often attributed to higher prevalence rates of heart conditions among men compared to women. The male segment is characterized by early onset of cardiovascular diseases, driving the need for transplantations. In contrast, the female segment is gaining traction as awareness increases around heart health in women, leading to an emerging need for transplants tailored to female patients. This segment is experiencing rapid growth, fueled by evolving healthcare policies and enhanced educational outreach on women's cardiovascular health.</p>

Get more detailed insights about Heart Transplant Market Research Report - Global Forecast till 2035

Regional Insights

North America : Market Leader in Heart Transplants

North America is poised to maintain its leadership in the heart transplant market, holding a significant market share of 6.5 billion in 2025. Key growth drivers include advanced healthcare infrastructure, increasing prevalence of cardiovascular diseases, and robust regulatory support for transplant procedures. The region's focus on innovation and research in transplant technologies further fuels demand, ensuring a steady growth trajectory. The competitive landscape in North America is characterized by the presence of major players such as Medtronic, Abbott Laboratories, and Boston Scientific. These companies are at the forefront of developing cutting-edge technologies and therapies that enhance transplant outcomes. The U.S. remains the leading country, supported by favorable policies and a high rate of organ donation, which collectively contribute to the region's dominance in the heart transplant market.

Europe : Emerging Market with Growth Potential

Europe's heart transplant market is valued at 3.5 billion, reflecting a growing demand driven by an aging population and increasing awareness of heart health. Regulatory frameworks across countries are evolving to support organ donation and transplantation, which is crucial for market expansion. The European Union's initiatives to harmonize transplant regulations are expected to further boost market growth, enhancing patient access to life-saving procedures. Leading countries in this region include Germany, France, and the UK, where healthcare systems are increasingly investing in transplant technologies. Key players like Sorin Group and Edwards Lifesciences are actively involved in this market, focusing on innovative solutions to improve transplant success rates. The competitive landscape is dynamic, with ongoing collaborations and partnerships aimed at enhancing patient care and outcomes in heart transplantation.

Asia-Pacific : Rapidly Growing Heart Transplant Market

The Asia-Pacific region, with a market size of 2.5 billion, is witnessing rapid growth in the heart transplant sector. Factors such as rising healthcare expenditure, increasing prevalence of heart diseases, and improving healthcare infrastructure are driving demand. Additionally, government initiatives aimed at enhancing organ donation awareness are expected to catalyze market growth, making this region a focal point for future investments in heart transplantation. Countries like Japan, China, and Australia are leading the charge in this market, supported by a growing number of healthcare facilities specializing in transplant procedures. Key players such as Terumo Corporation and Baxter International are expanding their presence in the region, focusing on innovative technologies and therapies. The competitive landscape is evolving, with a surge in collaborations aimed at improving transplant outcomes and patient care.

Middle East and Africa : Emerging Market with Challenges

The Middle East and Africa (MEA) heart transplant market, valued at 0.83 billion, is gradually emerging, driven by increasing healthcare investments and a growing awareness of heart health. However, challenges such as limited organ donation rates and varying healthcare infrastructure across countries hinder rapid growth. Regulatory bodies are working to improve organ donation frameworks, which is essential for market development in this region. Countries like South Africa and the UAE are at the forefront of heart transplant initiatives, with healthcare systems gradually adopting advanced transplant technologies. The presence of key players is limited, but companies are beginning to explore opportunities in this market. As awareness and healthcare access improve, the MEA region is expected to see gradual growth in heart transplantation, albeit at a slower pace compared to other regions.

Key Players and Competitive Insights

The Heart Transplant Market is characterized by a dynamic competitive landscape, driven by advancements in medical technology, increasing prevalence of heart diseases, and a growing demand for innovative treatment options. Key players such as Medtronic (US), Abbott Laboratories (US), and Edwards Lifesciences (US) are strategically positioned to leverage their expertise in medical devices and therapies. Medtronic (US) focuses on innovation through its extensive research and development initiatives, while Abbott Laboratories (US) emphasizes partnerships to enhance its product offerings. Edwards Lifesciences (US) is dedicated to advancing heart valve therapies, which positions it favorably in a market that increasingly prioritizes minimally invasive procedures. Collectively, these strategies contribute to a competitive environment that is both collaborative and competitive, fostering rapid advancements in heart transplant technologies.In terms of business tactics, companies are increasingly localizing manufacturing to reduce costs and enhance supply chain efficiency. This approach is particularly relevant in a moderately fragmented market where multiple players vie for market share. The collective influence of key players is significant, as they not only drive innovation but also set industry standards that smaller companies often follow. The competitive structure is evolving, with larger firms acquiring smaller entities to bolster their technological capabilities and market reach.

In November Medtronic (US) announced a strategic partnership with a leading biotechnology firm to develop next-generation heart transplant solutions. This collaboration is expected to enhance Medtronic's product pipeline, particularly in the realm of bioengineered tissues, which could revolutionize transplant procedures. The strategic importance of this partnership lies in its potential to accelerate innovation and improve patient outcomes, thereby solidifying Medtronic's leadership position in the market.

In October Abbott Laboratories (US) launched a new heart monitoring device that integrates AI technology to provide real-time data analytics for transplant patients. This device not only enhances patient monitoring but also allows for timely interventions, which is crucial in post-transplant care. The introduction of this technology underscores Abbott's commitment to digital transformation and positions the company as a frontrunner in the integration of AI within heart transplant care.

In September Edwards Lifesciences (US) expanded its product line with the introduction of a novel transcatheter heart valve designed for patients with specific anatomical challenges. This innovation reflects Edwards' focus on addressing unmet clinical needs and demonstrates its agility in responding to market demands. The strategic importance of this expansion lies in its potential to capture a niche segment of the market, thereby enhancing the company's competitive edge.

As of December current trends in the Heart Transplant Market are increasingly defined by digitalization, sustainability, and the integration of AI technologies. Strategic alliances are becoming more prevalent, as companies recognize the value of collaboration in driving innovation. Looking ahead, competitive differentiation is likely to evolve from traditional price-based competition to a focus on technological advancements, supply chain reliability, and the ability to deliver superior patient outcomes. This shift indicates a transformative phase in the market, where innovation and strategic partnerships will play pivotal roles in shaping the future landscape.

Key Companies in the Heart Transplant Market include

Industry Developments

2021:To carry out an Early Feasibility Study (EFS) of its TAH in the US, CARMAT received FDA permission.

2020:The HeartMate 3 Heart Pump's modified labelling for use in paediatric patients with advanced, refractory left ventricular heart failure has been approved by the FDA.

2020:The Impella CP Heart Pumps from Abiomed were given the green light by the Ministry of Health, Labour, and Welfare (MHLW) in Japan.

Future Outlook

Heart Transplant Market Future Outlook

The Heart Transplant Market is projected to grow at a 10.1% CAGR from 2025 to 2035, driven by advancements in surgical techniques, increasing donor organ availability, and rising prevalence of heart diseases.

New opportunities lie in:

  • Development of advanced immunosuppressive therapies to enhance transplant success rates.
  • Implementation of telemedicine platforms for post-transplant patient monitoring.
  • Expansion of organ preservation technologies to increase transplant viability and efficiency.

By 2035, the Heart Transplant Market is expected to be robust, reflecting significant advancements and increased accessibility.

Market Segmentation

Heart Transplant Market Age Group Outlook

  • Pediatric
  • Adult
  • Geriatric

Heart Transplant Market Application Outlook

  • Cardiac Failure
  • Coronary Artery Disease
  • Congenital Heart Defects
  • Valvular Heart Disease

Heart Transplant Market Type of Donor Outlook

  • Deceased Donor
  • Living Donor

Heart Transplant Market Surgical Technique Outlook

  • Orthotopic Transplantation
  • Heterotopic Transplantation
  • Minimally Invasive Surgery

Heart Transplant Market Post-Transplant Care Outlook

  • Immunosuppressive Therapy
  • Cardiac Rehabilitation
  • Long-term Monitoring

Report Scope

MARKET SIZE 2024 12.33(USD Billion)
MARKET SIZE 2025 13.58(USD Billion)
MARKET SIZE 2035 35.54(USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR) 10.1% (2025 - 2035)
REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR 2024
Market Forecast Period 2025 - 2035
Historical Data 2019 - 2024
Market Forecast Units USD Billion
Key Companies Profiled Medtronic (US), Abbott Laboratories (US), Boston Scientific (US), Terumo Corporation (JP), Cardinal Health (US), Baxter International (US), Edwards Lifesciences (US), Janssen Pharmaceuticals (US), Sorin Group (IT)
Segments Covered Application, Type of Donor, Age Group, Surgical Technique, Post-Transplant Care
Key Market Opportunities Advancements in organ preservation techniques enhance donor heart viability in the Heart Transplant Market.
Key Market Dynamics Technological advancements and regulatory changes are reshaping the competitive landscape of the heart transplant market.
Countries Covered North America, Europe, APAC, South America, MEA

FAQs

What is the current valuation of the Heart Transplant Market as of 2024?

<p>The Heart Transplant Market was valued at 12.33 USD Billion in 2024.</p>

What is the projected market size for the Heart Transplant Market by 2035?

<p>The market is projected to reach 35.54 USD Billion by 2035.</p>

What is the expected CAGR for the Heart Transplant Market during the forecast period 2025 - 2035?

<p>The expected CAGR for the Heart Transplant Market during 2025 - 2035 is 10.1%.</p>

Which application segment is projected to have the highest growth in the Heart Transplant Market?

<p>The Coronary Artery Disease segment is projected to grow from 4.0 USD Billion in 2024 to 11.0 USD Billion by 2035.</p>

How does the market size for living donor transplants compare to deceased donor transplants?

<p>In 2024, the market for living donor transplants was 4.93 USD Billion, while deceased donor transplants were valued at 7.4 USD Billion.</p>

What are the key players in the Heart Transplant Market?

<p>Key players include Abbott, Medtronic, Boston Scientific, and Terumo Corporation, among others.</p>

Which end-use segment is expected to see the most significant growth by 2035?

The Hospitals segment is expected to grow from 4.93 USD Billion in 2024 to 14.14 USD Billion by 2035.

What is the market size for pediatric heart transplants compared to adult and geriatric transplants?

Pediatric heart transplants were valued at 1.23 USD Billion in 2024, while adult and geriatric transplants were valued at 7.33 USD Billion and 3.77 USD Billion, respectively.

How does the gender distribution in the Heart Transplant Market appear?

In 2024, the market for male heart transplant patients was 7.4 USD Billion, compared to 4.93 USD Billion for female patients.

What trends are anticipated in the Heart Transplant Market by 2035?

The market is likely to experience substantial growth across all segments, driven by advancements in medical technology and increasing patient demand.

  1. SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. | 1.1 EXECUTIVE SUMMARY
    2. | | 1.1.1 Market Overview
    3. | | 1.1.2 Key Findings
    4. | | 1.1.3 Market Segmentation
    5. | | 1.1.4 Competitive Landscape
    6. | | 1.1.5 Challenges and Opportunities
    7. | | 1.1.6 Future Outlook
  2. SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. | 2.1 MARKET INTRODUCTION
    2. | | 2.1.1 Definition
    3. | | 2.1.2 Scope of the study
    4. | | | 2.1.2.1 Research Objective
    5. | | | 2.1.2.2 Assumption
    6. | | | 2.1.2.3 Limitations
    7. | 2.2 RESEARCH METHODOLOGY
    8. | | 2.2.1 Overview
    9. | | 2.2.2 Data Mining
    10. | | 2.2.3 Secondary Research
    11. | | 2.2.4 Primary Research
    12. | | | 2.2.4.1 Primary Interviews and Information Gathering Process
    13. | | | 2.2.4.2 Breakdown of Primary Respondents
    14. | | 2.2.5 Forecasting Model
    15. | | 2.2.6 Market Size Estimation
    16. | | | 2.2.6.1 Bottom-Up Approach
    17. | | | 2.2.6.2 Top-Down Approach
    18. | | 2.2.7 Data Triangulation
    19. | | 2.2.8 Validation
  3. SECTION III: QUALITATIVE ANALYSIS
    1. | 3.1 MARKET DYNAMICS
    2. | | 3.1.1 Overview
    3. | | 3.1.2 Drivers
    4. | | 3.1.3 Restraints
    5. | | 3.1.4 Opportunities
    6. | 3.2 MARKET FACTOR ANALYSIS
    7. | | 3.2.1 Value chain Analysis
    8. | | 3.2.2 Porter's Five Forces Analysis
    9. | | | 3.2.2.1 Bargaining Power of Suppliers
    10. | | | 3.2.2.2 Bargaining Power of Buyers
    11. | | | 3.2.2.3 Threat of New Entrants
    12. | | | 3.2.2.4 Threat of Substitutes
    13. | | | 3.2.2.5 Intensity of Rivalry
    14. | | 3.2.3 COVID-19 Impact Analysis
    15. | | | 3.2.3.1 Market Impact Analysis
    16. | | | 3.2.3.2 Regional Impact
    17. | | | 3.2.3.3 Opportunity and Threat Analysis
  4. SECTION IV: QUANTITATIVE ANALYSIS
    1. | 4.1 Healthcare, BY Application (USD Billion)
    2. | | 4.1.1 Cardiac Failure
    3. | | 4.1.2 Coronary Artery Disease
    4. | | 4.1.3 Congenital Heart Defects
    5. | | 4.1.4 Valvular Heart Disease
    6. | 4.2 Healthcare, BY End Use (USD Billion)
    7. | | 4.2.1 Hospitals
    8. | | 4.2.2 Specialized Heart Clinics
    9. | | 4.2.3 Transplant Centers
    10. | 4.3 Healthcare, BY Type of Donor (USD Billion)
    11. | | 4.3.1 Living Donor
    12. | | 4.3.2 Deceased Donor
    13. | 4.4 Healthcare, BY Age Group (USD Billion)
    14. | | 4.4.1 Pediatric
    15. | | 4.4.2 Adult
    16. | | 4.4.3 Geriatric
    17. | 4.5 Healthcare, BY Gender (USD Billion)
    18. | | 4.5.1 Male
    19. | | 4.5.2 Female
    20. | 4.6 Healthcare, BY Region (USD Billion)
    21. | | 4.6.1 North America
    22. | | | 4.6.1.1 US
    23. | | | 4.6.1.2 Canada
    24. | | 4.6.2 Europe
    25. | | | 4.6.2.1 Germany
    26. | | | 4.6.2.2 UK
    27. | | | 4.6.2.3 France
    28. | | | 4.6.2.4 Russia
    29. | | | 4.6.2.5 Italy
    30. | | | 4.6.2.6 Spain
    31. | | | 4.6.2.7 Rest of Europe
    32. | | 4.6.3 APAC
    33. | | | 4.6.3.1 China
    34. | | | 4.6.3.2 India
    35. | | | 4.6.3.3 Japan
    36. | | | 4.6.3.4 South Korea
    37. | | | 4.6.3.5 Malaysia
    38. | | | 4.6.3.6 Thailand
    39. | | | 4.6.3.7 Indonesia
    40. | | | 4.6.3.8 Rest of APAC
    41. | | 4.6.4 South America
    42. | | | 4.6.4.1 Brazil
    43. | | | 4.6.4.2 Mexico
    44. | | | 4.6.4.3 Argentina
    45. | | | 4.6.4.4 Rest of South America
    46. | | 4.6.5 MEA
    47. | | | 4.6.5.1 GCC Countries
    48. | | | 4.6.5.2 South Africa
    49. | | | 4.6.5.3 Rest of MEA
  5. SECTION V: COMPETITIVE ANALYSIS
    1. | 5.1 Competitive Landscape
    2. | | 5.1.1 Overview
    3. | | 5.1.2 Competitive Analysis
    4. | | 5.1.3 Market share Analysis
    5. | | 5.1.4 Major Growth Strategy in the Healthcare
    6. | | 5.1.5 Competitive Benchmarking
    7. | | 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
    8. | | 5.1.7 Key developments and growth strategies
    9. | | | 5.1.7.1 New Product Launch/Service Deployment
    10. | | | 5.1.7.2 Merger & Acquisitions
    11. | | | 5.1.7.3 Joint Ventures
    12. | | 5.1.8 Major Players Financial Matrix
    13. | | | 5.1.8.1 Sales and Operating Income
    14. | | | 5.1.8.2 Major Players R&D Expenditure. 2023
    15. | 5.2 Company Profiles
    16. | | 5.2.1 Abbott (US)
    17. | | | 5.2.1.1 Financial Overview
    18. | | | 5.2.1.2 Products Offered
    19. | | | 5.2.1.3 Key Developments
    20. | | | 5.2.1.4 SWOT Analysis
    21. | | | 5.2.1.5 Key Strategies
    22. | | 5.2.2 Medtronic (US)
    23. | | | 5.2.2.1 Financial Overview
    24. | | | 5.2.2.2 Products Offered
    25. | | | 5.2.2.3 Key Developments
    26. | | | 5.2.2.4 SWOT Analysis
    27. | | | 5.2.2.5 Key Strategies
    28. | | 5.2.3 Boston Scientific (US)
    29. | | | 5.2.3.1 Financial Overview
    30. | | | 5.2.3.2 Products Offered
    31. | | | 5.2.3.3 Key Developments
    32. | | | 5.2.3.4 SWOT Analysis
    33. | | | 5.2.3.5 Key Strategies
    34. | | 5.2.4 Terumo Corporation (JP)
    35. | | | 5.2.4.1 Financial Overview
    36. | | | 5.2.4.2 Products Offered
    37. | | | 5.2.4.3 Key Developments
    38. | | | 5.2.4.4 SWOT Analysis
    39. | | | 5.2.4.5 Key Strategies
    40. | | 5.2.5 Cardinal Health (US)
    41. | | | 5.2.5.1 Financial Overview
    42. | | | 5.2.5.2 Products Offered
    43. | | | 5.2.5.3 Key Developments
    44. | | | 5.2.5.4 SWOT Analysis
    45. | | | 5.2.5.5 Key Strategies
    46. | | 5.2.6 Baxter International (US)
    47. | | | 5.2.6.1 Financial Overview
    48. | | | 5.2.6.2 Products Offered
    49. | | | 5.2.6.3 Key Developments
    50. | | | 5.2.6.4 SWOT Analysis
    51. | | | 5.2.6.5 Key Strategies
    52. | | 5.2.7 Edwards Lifesciences (US)
    53. | | | 5.2.7.1 Financial Overview
    54. | | | 5.2.7.2 Products Offered
    55. | | | 5.2.7.3 Key Developments
    56. | | | 5.2.7.4 SWOT Analysis
    57. | | | 5.2.7.5 Key Strategies
    58. | | 5.2.8 Sorin Group (IT)
    59. | | | 5.2.8.1 Financial Overview
    60. | | | 5.2.8.2 Products Offered
    61. | | | 5.2.8.3 Key Developments
    62. | | | 5.2.8.4 SWOT Analysis
    63. | | | 5.2.8.5 Key Strategies
    64. | | 5.2.9 Janssen Pharmaceuticals (US)
    65. | | | 5.2.9.1 Financial Overview
    66. | | | 5.2.9.2 Products Offered
    67. | | | 5.2.9.3 Key Developments
    68. | | | 5.2.9.4 SWOT Analysis
    69. | | | 5.2.9.5 Key Strategies
    70. | 5.3 Appendix
    71. | | 5.3.1 References
    72. | | 5.3.2 Related Reports
  6. LIST OF FIGURES
    1. | 6.1 MARKET SYNOPSIS
    2. | 6.2 NORTH AMERICA MARKET ANALYSIS
    3. | 6.3 US MARKET ANALYSIS BY APPLICATION
    4. | 6.4 US MARKET ANALYSIS BY END USE
    5. | 6.5 US MARKET ANALYSIS BY TYPE OF DONOR
    6. | 6.6 US MARKET ANALYSIS BY AGE GROUP
    7. | 6.7 US MARKET ANALYSIS BY GENDER
    8. | 6.8 CANADA MARKET ANALYSIS BY APPLICATION
    9. | 6.9 CANADA MARKET ANALYSIS BY END USE
    10. | 6.10 CANADA MARKET ANALYSIS BY TYPE OF DONOR
    11. | 6.11 CANADA MARKET ANALYSIS BY AGE GROUP
    12. | 6.12 CANADA MARKET ANALYSIS BY GENDER
    13. | 6.13 EUROPE MARKET ANALYSIS
    14. | 6.14 GERMANY MARKET ANALYSIS BY APPLICATION
    15. | 6.15 GERMANY MARKET ANALYSIS BY END USE
    16. | 6.16 GERMANY MARKET ANALYSIS BY TYPE OF DONOR
    17. | 6.17 GERMANY MARKET ANALYSIS BY AGE GROUP
    18. | 6.18 GERMANY MARKET ANALYSIS BY GENDER
    19. | 6.19 UK MARKET ANALYSIS BY APPLICATION
    20. | 6.20 UK MARKET ANALYSIS BY END USE
    21. | 6.21 UK MARKET ANALYSIS BY TYPE OF DONOR
    22. | 6.22 UK MARKET ANALYSIS BY AGE GROUP
    23. | 6.23 UK MARKET ANALYSIS BY GENDER
    24. | 6.24 FRANCE MARKET ANALYSIS BY APPLICATION
    25. | 6.25 FRANCE MARKET ANALYSIS BY END USE
    26. | 6.26 FRANCE MARKET ANALYSIS BY TYPE OF DONOR
    27. | 6.27 FRANCE MARKET ANALYSIS BY AGE GROUP
    28. | 6.28 FRANCE MARKET ANALYSIS BY GENDER
    29. | 6.29 RUSSIA MARKET ANALYSIS BY APPLICATION
    30. | 6.30 RUSSIA MARKET ANALYSIS BY END USE
    31. | 6.31 RUSSIA MARKET ANALYSIS BY TYPE OF DONOR
    32. | 6.32 RUSSIA MARKET ANALYSIS BY AGE GROUP
    33. | 6.33 RUSSIA MARKET ANALYSIS BY GENDER
    34. | 6.34 ITALY MARKET ANALYSIS BY APPLICATION
    35. | 6.35 ITALY MARKET ANALYSIS BY END USE
    36. | 6.36 ITALY MARKET ANALYSIS BY TYPE OF DONOR
    37. | 6.37 ITALY MARKET ANALYSIS BY AGE GROUP
    38. | 6.38 ITALY MARKET ANALYSIS BY GENDER
    39. | 6.39 SPAIN MARKET ANALYSIS BY APPLICATION
    40. | 6.40 SPAIN MARKET ANALYSIS BY END USE
    41. | 6.41 SPAIN MARKET ANALYSIS BY TYPE OF DONOR
    42. | 6.42 SPAIN MARKET ANALYSIS BY AGE GROUP
    43. | 6.43 SPAIN MARKET ANALYSIS BY GENDER
    44. | 6.44 REST OF EUROPE MARKET ANALYSIS BY APPLICATION
    45. | 6.45 REST OF EUROPE MARKET ANALYSIS BY END USE
    46. | 6.46 REST OF EUROPE MARKET ANALYSIS BY TYPE OF DONOR
    47. | 6.47 REST OF EUROPE MARKET ANALYSIS BY AGE GROUP
    48. | 6.48 REST OF EUROPE MARKET ANALYSIS BY GENDER
    49. | 6.49 APAC MARKET ANALYSIS
    50. | 6.50 CHINA MARKET ANALYSIS BY APPLICATION
    51. | 6.51 CHINA MARKET ANALYSIS BY END USE
    52. | 6.52 CHINA MARKET ANALYSIS BY TYPE OF DONOR
    53. | 6.53 CHINA MARKET ANALYSIS BY AGE GROUP
    54. | 6.54 CHINA MARKET ANALYSIS BY GENDER
    55. | 6.55 INDIA MARKET ANALYSIS BY APPLICATION
    56. | 6.56 INDIA MARKET ANALYSIS BY END USE
    57. | 6.57 INDIA MARKET ANALYSIS BY TYPE OF DONOR
    58. | 6.58 INDIA MARKET ANALYSIS BY AGE GROUP
    59. | 6.59 INDIA MARKET ANALYSIS BY GENDER
    60. | 6.60 JAPAN MARKET ANALYSIS BY APPLICATION
    61. | 6.61 JAPAN MARKET ANALYSIS BY END USE
    62. | 6.62 JAPAN MARKET ANALYSIS BY TYPE OF DONOR
    63. | 6.63 JAPAN MARKET ANALYSIS BY AGE GROUP
    64. | 6.64 JAPAN MARKET ANALYSIS BY GENDER
    65. | 6.65 SOUTH KOREA MARKET ANALYSIS BY APPLICATION
    66. | 6.66 SOUTH KOREA MARKET ANALYSIS BY END USE
    67. | 6.67 SOUTH KOREA MARKET ANALYSIS BY TYPE OF DONOR
    68. | 6.68 SOUTH KOREA MARKET ANALYSIS BY AGE GROUP
    69. | 6.69 SOUTH KOREA MARKET ANALYSIS BY GENDER
    70. | 6.70 MALAYSIA MARKET ANALYSIS BY APPLICATION
    71. | 6.71 MALAYSIA MARKET ANALYSIS BY END USE
    72. | 6.72 MALAYSIA MARKET ANALYSIS BY TYPE OF DONOR
    73. | 6.73 MALAYSIA MARKET ANALYSIS BY AGE GROUP
    74. | 6.74 MALAYSIA MARKET ANALYSIS BY GENDER
    75. | 6.75 THAILAND MARKET ANALYSIS BY APPLICATION
    76. | 6.76 THAILAND MARKET ANALYSIS BY END USE
    77. | 6.77 THAILAND MARKET ANALYSIS BY TYPE OF DONOR
    78. | 6.78 THAILAND MARKET ANALYSIS BY AGE GROUP
    79. | 6.79 THAILAND MARKET ANALYSIS BY GENDER
    80. | 6.80 INDONESIA MARKET ANALYSIS BY APPLICATION
    81. | 6.81 INDONESIA MARKET ANALYSIS BY END USE
    82. | 6.82 INDONESIA MARKET ANALYSIS BY TYPE OF DONOR
    83. | 6.83 INDONESIA MARKET ANALYSIS BY AGE GROUP
    84. | 6.84 INDONESIA MARKET ANALYSIS BY GENDER
    85. | 6.85 REST OF APAC MARKET ANALYSIS BY APPLICATION
    86. | 6.86 REST OF APAC MARKET ANALYSIS BY END USE
    87. | 6.87 REST OF APAC MARKET ANALYSIS BY TYPE OF DONOR
    88. | 6.88 REST OF APAC MARKET ANALYSIS BY AGE GROUP
    89. | 6.89 REST OF APAC MARKET ANALYSIS BY GENDER
    90. | 6.90 SOUTH AMERICA MARKET ANALYSIS
    91. | 6.91 BRAZIL MARKET ANALYSIS BY APPLICATION
    92. | 6.92 BRAZIL MARKET ANALYSIS BY END USE
    93. | 6.93 BRAZIL MARKET ANALYSIS BY TYPE OF DONOR
    94. | 6.94 BRAZIL MARKET ANALYSIS BY AGE GROUP
    95. | 6.95 BRAZIL MARKET ANALYSIS BY GENDER
    96. | 6.96 MEXICO MARKET ANALYSIS BY APPLICATION
    97. | 6.97 MEXICO MARKET ANALYSIS BY END USE
    98. | 6.98 MEXICO MARKET ANALYSIS BY TYPE OF DONOR
    99. | 6.99 MEXICO MARKET ANALYSIS BY AGE GROUP
    100. | 6.100 MEXICO MARKET ANALYSIS BY GENDER
    101. | 6.101 ARGENTINA MARKET ANALYSIS BY APPLICATION
    102. | 6.102 ARGENTINA MARKET ANALYSIS BY END USE
    103. | 6.103 ARGENTINA MARKET ANALYSIS BY TYPE OF DONOR
    104. | 6.104 ARGENTINA MARKET ANALYSIS BY AGE GROUP
    105. | 6.105 ARGENTINA MARKET ANALYSIS BY GENDER
    106. | 6.106 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION
    107. | 6.107 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USE
    108. | 6.108 REST OF SOUTH AMERICA MARKET ANALYSIS BY TYPE OF DONOR
    109. | 6.109 REST OF SOUTH AMERICA MARKET ANALYSIS BY AGE GROUP
    110. | 6.110 REST OF SOUTH AMERICA MARKET ANALYSIS BY GENDER
    111. | 6.111 MEA MARKET ANALYSIS
    112. | 6.112 GCC COUNTRIES MARKET ANALYSIS BY APPLICATION
    113. | 6.113 GCC COUNTRIES MARKET ANALYSIS BY END USE
    114. | 6.114 GCC COUNTRIES MARKET ANALYSIS BY TYPE OF DONOR
    115. | 6.115 GCC COUNTRIES MARKET ANALYSIS BY AGE GROUP
    116. | 6.116 GCC COUNTRIES MARKET ANALYSIS BY GENDER
    117. | 6.117 SOUTH AFRICA MARKET ANALYSIS BY APPLICATION
    118. | 6.118 SOUTH AFRICA MARKET ANALYSIS BY END USE
    119. | 6.119 SOUTH AFRICA MARKET ANALYSIS BY TYPE OF DONOR
    120. | 6.120 SOUTH AFRICA MARKET ANALYSIS BY AGE GROUP
    121. | 6.121 SOUTH AFRICA MARKET ANALYSIS BY GENDER
    122. | 6.122 REST OF MEA MARKET ANALYSIS BY APPLICATION
    123. | 6.123 REST OF MEA MARKET ANALYSIS BY END USE
    124. | 6.124 REST OF MEA MARKET ANALYSIS BY TYPE OF DONOR
    125. | 6.125 REST OF MEA MARKET ANALYSIS BY AGE GROUP
    126. | 6.126 REST OF MEA MARKET ANALYSIS BY GENDER
    127. | 6.127 KEY BUYING CRITERIA OF HEALTHCARE
    128. | 6.128 RESEARCH PROCESS OF MRFR
    129. | 6.129 DRO ANALYSIS OF HEALTHCARE
    130. | 6.130 DRIVERS IMPACT ANALYSIS: HEALTHCARE
    131. | 6.131 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
    132. | 6.132 SUPPLY / VALUE CHAIN: HEALTHCARE
    133. | 6.133 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
    134. | 6.134 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Billion)
    135. | 6.135 HEALTHCARE, BY END USE, 2024 (% SHARE)
    136. | 6.136 HEALTHCARE, BY END USE, 2024 TO 2035 (USD Billion)
    137. | 6.137 HEALTHCARE, BY TYPE OF DONOR, 2024 (% SHARE)
    138. | 6.138 HEALTHCARE, BY TYPE OF DONOR, 2024 TO 2035 (USD Billion)
    139. | 6.139 HEALTHCARE, BY AGE GROUP, 2024 (% SHARE)
    140. | 6.140 HEALTHCARE, BY AGE GROUP, 2024 TO 2035 (USD Billion)
    141. | 6.141 HEALTHCARE, BY GENDER, 2024 (% SHARE)
    142. | 6.142 HEALTHCARE, BY GENDER, 2024 TO 2035 (USD Billion)
    143. | 6.143 BENCHMARKING OF MAJOR COMPETITORS
  7. LIST OF TABLES
    1. | 7.1 LIST OF ASSUMPTIONS
    2. | | 7.1.1
    3. | 7.2 North America MARKET SIZE ESTIMATES; FORECAST
    4. | | 7.2.1 BY APPLICATION, 2025-2035 (USD Billion)
    5. | | 7.2.2 BY END USE, 2025-2035 (USD Billion)
    6. | | 7.2.3 BY TYPE OF DONOR, 2025-2035 (USD Billion)
    7. | | 7.2.4 BY AGE GROUP, 2025-2035 (USD Billion)
    8. | | 7.2.5 BY GENDER, 2025-2035 (USD Billion)
    9. | 7.3 US MARKET SIZE ESTIMATES; FORECAST
    10. | | 7.3.1 BY APPLICATION, 2025-2035 (USD Billion)
    11. | | 7.3.2 BY END USE, 2025-2035 (USD Billion)
    12. | | 7.3.3 BY TYPE OF DONOR, 2025-2035 (USD Billion)
    13. | | 7.3.4 BY AGE GROUP, 2025-2035 (USD Billion)
    14. | | 7.3.5 BY GENDER, 2025-2035 (USD Billion)
    15. | 7.4 Canada MARKET SIZE ESTIMATES; FORECAST
    16. | | 7.4.1 BY APPLICATION, 2025-2035 (USD Billion)
    17. | | 7.4.2 BY END USE, 2025-2035 (USD Billion)
    18. | | 7.4.3 BY TYPE OF DONOR, 2025-2035 (USD Billion)
    19. | | 7.4.4 BY AGE GROUP, 2025-2035 (USD Billion)
    20. | | 7.4.5 BY GENDER, 2025-2035 (USD Billion)
    21. | 7.5 Europe MARKET SIZE ESTIMATES; FORECAST
    22. | | 7.5.1 BY APPLICATION, 2025-2035 (USD Billion)
    23. | | 7.5.2 BY END USE, 2025-2035 (USD Billion)
    24. | | 7.5.3 BY TYPE OF DONOR, 2025-2035 (USD Billion)
    25. | | 7.5.4 BY AGE GROUP, 2025-2035 (USD Billion)
    26. | | 7.5.5 BY GENDER, 2025-2035 (USD Billion)
    27. | 7.6 Germany MARKET SIZE ESTIMATES; FORECAST
    28. | | 7.6.1 BY APPLICATION, 2025-2035 (USD Billion)
    29. | | 7.6.2 BY END USE, 2025-2035 (USD Billion)
    30. | | 7.6.3 BY TYPE OF DONOR, 2025-2035 (USD Billion)
    31. | | 7.6.4 BY AGE GROUP, 2025-2035 (USD Billion)
    32. | | 7.6.5 BY GENDER, 2025-2035 (USD Billion)
    33. | 7.7 UK MARKET SIZE ESTIMATES; FORECAST
    34. | | 7.7.1 BY APPLICATION, 2025-2035 (USD Billion)
    35. | | 7.7.2 BY END USE, 2025-2035 (USD Billion)
    36. | | 7.7.3 BY TYPE OF DONOR, 2025-2035 (USD Billion)
    37. | | 7.7.4 BY AGE GROUP, 2025-2035 (USD Billion)
    38. | | 7.7.5 BY GENDER, 2025-2035 (USD Billion)
    39. | 7.8 France MARKET SIZE ESTIMATES; FORECAST
    40. | | 7.8.1 BY APPLICATION, 2025-2035 (USD Billion)
    41. | | 7.8.2 BY END USE, 2025-2035 (USD Billion)
    42. | | 7.8.3 BY TYPE OF DONOR, 2025-2035 (USD Billion)
    43. | | 7.8.4 BY AGE GROUP, 2025-2035 (USD Billion)
    44. | | 7.8.5 BY GENDER, 2025-2035 (USD Billion)
    45. | 7.9 Russia MARKET SIZE ESTIMATES; FORECAST
    46. | | 7.9.1 BY APPLICATION, 2025-2035 (USD Billion)
    47. | | 7.9.2 BY END USE, 2025-2035 (USD Billion)
    48. | | 7.9.3 BY TYPE OF DONOR, 2025-2035 (USD Billion)
    49. | | 7.9.4 BY AGE GROUP, 2025-2035 (USD Billion)
    50. | | 7.9.5 BY GENDER, 2025-2035 (USD Billion)
    51. | 7.10 Italy MARKET SIZE ESTIMATES; FORECAST
    52. | | 7.10.1 BY APPLICATION, 2025-2035 (USD Billion)
    53. | | 7.10.2 BY END USE, 2025-2035 (USD Billion)
    54. | | 7.10.3 BY TYPE OF DONOR, 2025-2035 (USD Billion)
    55. | | 7.10.4 BY AGE GROUP, 2025-2035 (USD Billion)
    56. | | 7.10.5 BY GENDER, 2025-2035 (USD Billion)
    57. | 7.11 Spain MARKET SIZE ESTIMATES; FORECAST
    58. | | 7.11.1 BY APPLICATION, 2025-2035 (USD Billion)
    59. | | 7.11.2 BY END USE, 2025-2035 (USD Billion)
    60. | | 7.11.3 BY TYPE OF DONOR, 2025-2035 (USD Billion)
    61. | | 7.11.4 BY AGE GROUP, 2025-2035 (USD Billion)
    62. | | 7.11.5 BY GENDER, 2025-2035 (USD Billion)
    63. | 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
    64. | | 7.12.1 BY APPLICATION, 2025-2035 (USD Billion)
    65. | | 7.12.2 BY END USE, 2025-2035 (USD Billion)
    66. | | 7.12.3 BY TYPE OF DONOR, 2025-2035 (USD Billion)
    67. | | 7.12.4 BY AGE GROUP, 2025-2035 (USD Billion)
    68. | | 7.12.5 BY GENDER, 2025-2035 (USD Billion)
    69. | 7.13 APAC MARKET SIZE ESTIMATES; FORECAST
    70. | | 7.13.1 BY APPLICATION, 2025-2035 (USD Billion)
    71. | | 7.13.2 BY END USE, 2025-2035 (USD Billion)
    72. | | 7.13.3 BY TYPE OF DONOR, 2025-2035 (USD Billion)
    73. | | 7.13.4 BY AGE GROUP, 2025-2035 (USD Billion)
    74. | | 7.13.5 BY GENDER, 2025-2035 (USD Billion)
    75. | 7.14 China MARKET SIZE ESTIMATES; FORECAST
    76. | | 7.14.1 BY APPLICATION, 2025-2035 (USD Billion)
    77. | | 7.14.2 BY END USE, 2025-2035 (USD Billion)
    78. | | 7.14.3 BY TYPE OF DONOR, 2025-2035 (USD Billion)
    79. | | 7.14.4 BY AGE GROUP, 2025-2035 (USD Billion)
    80. | | 7.14.5 BY GENDER, 2025-2035 (USD Billion)
    81. | 7.15 India MARKET SIZE ESTIMATES; FORECAST
    82. | | 7.15.1 BY APPLICATION, 2025-2035 (USD Billion)
    83. | | 7.15.2 BY END USE, 2025-2035 (USD Billion)
    84. | | 7.15.3 BY TYPE OF DONOR, 2025-2035 (USD Billion)
    85. | | 7.15.4 BY AGE GROUP, 2025-2035 (USD Billion)
    86. | | 7.15.5 BY GENDER, 2025-2035 (USD Billion)
    87. | 7.16 Japan MARKET SIZE ESTIMATES; FORECAST
    88. | | 7.16.1 BY APPLICATION, 2025-2035 (USD Billion)
    89. | | 7.16.2 BY END USE, 2025-2035 (USD Billion)
    90. | | 7.16.3 BY TYPE OF DONOR, 2025-2035 (USD Billion)
    91. | | 7.16.4 BY AGE GROUP, 2025-2035 (USD Billion)
    92. | | 7.16.5 BY GENDER, 2025-2035 (USD Billion)
    93. | 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
    94. | | 7.17.1 BY APPLICATION, 2025-2035 (USD Billion)
    95. | | 7.17.2 BY END USE, 2025-2035 (USD Billion)
    96. | | 7.17.3 BY TYPE OF DONOR, 2025-2035 (USD Billion)
    97. | | 7.17.4 BY AGE GROUP, 2025-2035 (USD Billion)
    98. | | 7.17.5 BY GENDER, 2025-2035 (USD Billion)
    99. | 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
    100. | | 7.18.1 BY APPLICATION, 2025-2035 (USD Billion)
    101. | | 7.18.2 BY END USE, 2025-2035 (USD Billion)
    102. | | 7.18.3 BY TYPE OF DONOR, 2025-2035 (USD Billion)
    103. | | 7.18.4 BY AGE GROUP, 2025-2035 (USD Billion)
    104. | | 7.18.5 BY GENDER, 2025-2035 (USD Billion)
    105. | 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
    106. | | 7.19.1 BY APPLICATION, 2025-2035 (USD Billion)
    107. | | 7.19.2 BY END USE, 2025-2035 (USD Billion)
    108. | | 7.19.3 BY TYPE OF DONOR, 2025-2035 (USD Billion)
    109. | | 7.19.4 BY AGE GROUP, 2025-2035 (USD Billion)
    110. | | 7.19.5 BY GENDER, 2025-2035 (USD Billion)
    111. | 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
    112. | | 7.20.1 BY APPLICATION, 2025-2035 (USD Billion)
    113. | | 7.20.2 BY END USE, 2025-2035 (USD Billion)
    114. | | 7.20.3 BY TYPE OF DONOR, 2025-2035 (USD Billion)
    115. | | 7.20.4 BY AGE GROUP, 2025-2035 (USD Billion)
    116. | | 7.20.5 BY GENDER, 2025-2035 (USD Billion)
    117. | 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
    118. | | 7.21.1 BY APPLICATION, 2025-2035 (USD Billion)
    119. | | 7.21.2 BY END USE, 2025-2035 (USD Billion)
    120. | | 7.21.3 BY TYPE OF DONOR, 2025-2035 (USD Billion)
    121. | | 7.21.4 BY AGE GROUP, 2025-2035 (USD Billion)
    122. | | 7.21.5 BY GENDER, 2025-2035 (USD Billion)
    123. | 7.22 South America MARKET SIZE ESTIMATES; FORECAST
    124. | | 7.22.1 BY APPLICATION, 2025-2035 (USD Billion)
    125. | | 7.22.2 BY END USE, 2025-2035 (USD Billion)
    126. | | 7.22.3 BY TYPE OF DONOR, 2025-2035 (USD Billion)
    127. | | 7.22.4 BY AGE GROUP, 2025-2035 (USD Billion)
    128. | | 7.22.5 BY GENDER, 2025-2035 (USD Billion)
    129. | 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
    130. | | 7.23.1 BY APPLICATION, 2025-2035 (USD Billion)
    131. | | 7.23.2 BY END USE, 2025-2035 (USD Billion)
    132. | | 7.23.3 BY TYPE OF DONOR, 2025-2035 (USD Billion)
    133. | | 7.23.4 BY AGE GROUP, 2025-2035 (USD Billion)
    134. | | 7.23.5 BY GENDER, 2025-2035 (USD Billion)
    135. | 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
    136. | | 7.24.1 BY APPLICATION, 2025-2035 (USD Billion)
    137. | | 7.24.2 BY END USE, 2025-2035 (USD Billion)
    138. | | 7.24.3 BY TYPE OF DONOR, 2025-2035 (USD Billion)
    139. | | 7.24.4 BY AGE GROUP, 2025-2035 (USD Billion)
    140. | | 7.24.5 BY GENDER, 2025-2035 (USD Billion)
    141. | 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
    142. | | 7.25.1 BY APPLICATION, 2025-2035 (USD Billion)
    143. | | 7.25.2 BY END USE, 2025-2035 (USD Billion)
    144. | | 7.25.3 BY TYPE OF DONOR, 2025-2035 (USD Billion)
    145. | | 7.25.4 BY AGE GROUP, 2025-2035 (USD Billion)
    146. | | 7.25.5 BY GENDER, 2025-2035 (USD Billion)
    147. | 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
    148. | | 7.26.1 BY APPLICATION, 2025-2035 (USD Billion)
    149. | | 7.26.2 BY END USE, 2025-2035 (USD Billion)
    150. | | 7.26.3 BY TYPE OF DONOR, 2025-2035 (USD Billion)
    151. | | 7.26.4 BY AGE GROUP, 2025-2035 (USD Billion)
    152. | | 7.26.5 BY GENDER, 2025-2035 (USD Billion)
    153. | 7.27 MEA MARKET SIZE ESTIMATES; FORECAST
    154. | | 7.27.1 BY APPLICATION, 2025-2035 (USD Billion)
    155. | | 7.27.2 BY END USE, 2025-2035 (USD Billion)
    156. | | 7.27.3 BY TYPE OF DONOR, 2025-2035 (USD Billion)
    157. | | 7.27.4 BY AGE GROUP, 2025-2035 (USD Billion)
    158. | | 7.27.5 BY GENDER, 2025-2035 (USD Billion)
    159. | 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
    160. | | 7.28.1 BY APPLICATION, 2025-2035 (USD Billion)
    161. | | 7.28.2 BY END USE, 2025-2035 (USD Billion)
    162. | | 7.28.3 BY TYPE OF DONOR, 2025-2035 (USD Billion)
    163. | | 7.28.4 BY AGE GROUP, 2025-2035 (USD Billion)
    164. | | 7.28.5 BY GENDER, 2025-2035 (USD Billion)
    165. | 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
    166. | | 7.29.1 BY APPLICATION, 2025-2035 (USD Billion)
    167. | | 7.29.2 BY END USE, 2025-2035 (USD Billion)
    168. | | 7.29.3 BY TYPE OF DONOR, 2025-2035 (USD Billion)
    169. | | 7.29.4 BY AGE GROUP, 2025-2035 (USD Billion)
    170. | | 7.29.5 BY GENDER, 2025-2035 (USD Billion)
    171. | 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
    172. | | 7.30.1 BY APPLICATION, 2025-2035 (USD Billion)
    173. | | 7.30.2 BY END USE, 2025-2035 (USD Billion)
    174. | | 7.30.3 BY TYPE OF DONOR, 2025-2035 (USD Billion)
    175. | | 7.30.4 BY AGE GROUP, 2025-2035 (USD Billion)
    176. | | 7.30.5 BY GENDER, 2025-2035 (USD Billion)
    177. | 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
    178. | | 7.31.1
    179. | 7.32 ACQUISITION/PARTNERSHIP
    180. | | 7.32.1

Healthcare Market Segmentation

Healthcare By Application (USD Billion, 2025-2035)

  • Cardiac Failure
  • Coronary Artery Disease
  • Congenital Heart Defects
  • Valvular Heart Disease

Healthcare By End Use (USD Billion, 2025-2035)

  • Hospitals
  • Specialized Heart Clinics
  • Transplant Centers

Healthcare By Type of Donor (USD Billion, 2025-2035)

  • Living Donor
  • Deceased Donor

Healthcare By Age Group (USD Billion, 2025-2035)

  • Pediatric
  • Adult
  • Geriatric

Healthcare By Gender (USD Billion, 2025-2035)

  • Male
  • Female
Infographic

Free Sample Request

Kindly complete the form below to receive a free sample of this Report

Get Free Sample

Related Reports

Regional Reports
Country Reports

Customer Strories

Customer Stories
Case Study Cover Image
Case Study
Aerospace & Defense
Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓